Innate Pharma SA-Spons ADRIPHA
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 9 institutions reported holding Innate Pharma SA-Spons ADR (IPHA) in their 13F filings, down 1 from Q1 2025. 1 opened new positions and 2 sold out. The largest holders were Morgan Stanley ($93K), Citadel Advisors ($47K) and Millennium Management ($20K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Innate Pharma SA-Spons ADR
- CUSIP
- 45781K204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $82 |
| Exits | 2 | $112K |
All 13F filers, Q1 2025 → Q2 2025: 11,318 shares bought and 69,669 shares sold, net −58,351 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Morgan Stanley | 0.00% | Add +17.7% | 51,224 | $93K |
| Citadel Advisors | 0.00% | Add +9.7% | 26,617 | $47K |
| Millennium Management | 0.00% | Reduce -23.9% | 11,661 | $20K |
| UBS Group AG | 0.00% | Reduce -33.8% | 5,957 | $11K |
| GAMMA Investing LLC | 0.00% | Add +54.8% | 3,456 | $6K |
| Rhumbline Advisers | 0.00% | Reduce -30.4% | 470 | $822 |
| Barclays PLC | 0.00% | No change | 307 | $557 |
| Optiver Holding B.V. | 0.00% | No change | 101 | $177 |
| Principal Securities, Inc. | 0.00% | New | 45 | $82 |
"% of holder's portfolio" is IPHA's weight in each manager's 13F, not the share of Innate Pharma SA-Spons ADR the manager owns.